Israel’s BioGenCell (see here previously) is conducting Phase 2 trials of its Tissue Regenerative Activated Cell (TRACT) Therapy. It is preventing amputations at Netanya’s Laniado Medical Center, the US (Yale and Johns Hopkins), Belgium, and Georgia. It is now raising funds for Phase 3 trials.
Preventing clash of medications
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.